Cargando…
Guidance on nebulization during the current COVID-19 pandemic
Awareness of the risk of airborne transmission of SARS-CoV-2 makes patients hesitant about using inhaled medications that are considered as a potential source of viral transmission and immunosuppression. However, patients with asthma or COPD should continue all prescribed inhaled medications. Appare...
Autores principales: | Cazzola, Mario, Ora, Josuel, Bianco, Andrea, Rogliani, Paola, Matera, Maria Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676318/ https://www.ncbi.nlm.nih.gov/pubmed/33248363 http://dx.doi.org/10.1016/j.rmed.2020.106236 |
Ejemplares similares
-
Use of Thiols in the Treatment of COVID-19: Current Evidence
por: Cazzola, Mario, et al.
Publicado: (2021) -
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
por: Rogliani, Paola, et al.
Publicado: (2017) -
Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis
por: Rogliani, Paola, et al.
Publicado: (2019) -
New Avenues for Phosphodiesterase Inhibitors in Asthma
por: Matera, Maria Gabriella, et al.
Publicado: (2021) -
Treatable Mechanisms in Asthma
por: Cazzola, Mario, et al.
Publicado: (2021)